EU Pharma Package

Hybrid threats force Poland to tighten medicine supply controls
Belgium’s biotech ultimatum 'cut red tape, and increase funding' or lose globally
Critical Medicines Act needs more flexibility for diverse supply chains, says industry
Irish pharma sector hails €30m medicines boost and R&D tax credit increase
Parliament and Council wrap up second pharma talks, eye November for breakthrough
Bulgaria’s rebate policy risks limiting medicine access
Countries push back at Danish bid for flexibility in pharma talks
1 2 3 4 5 39